2017

Westborg I, Albrecht S, Rosso A. Risk for low visual acuity after 1 and 2 years of treatment with ranibizumab or bevacizumab for patients with neovascular age-related macular degeneration. Retina 2017.

FacebookTwitterDela gärna
Publicerad: 22 februari 2017
Senast uppdaterad: 22 februari 2017